Navigation Links
Targeted investigational therapy potential to overcome crizotinib resistance in lung cancers
Date:10/20/2013

BOSTON PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

About 3 to 5 percent of lung cancers harbor ALK gene abnormalities. The drug crizotinib (Xalkori), which blocks ALK protein kinase activity, was approved in August 2011 by the U.S. Food and Drug Administration for the treatment of patients who have these lung cancers. Although robust responses to crizotinib are observed for lung cancers harboring ALK gene abnormalities, the majority eventually become resistant to the effects of the drug. In many cases, resistance arises because of genetic mutations in ALK.

"Resistance to targeted therapies such as crizotinib is a major challenge when treating patients with cancer," said Tod Smeal, Ph.D., associate research fellow in the Oncology Research Unit at Pfizer Inc. in San Diego, Calif. "Our goal is to take advantage of everything we have learned about designing drugs that target kinases like ALK and the ways in which lung cancers become resistant to crizotinib to develop the best next-generation ALK inhibitor we can.

"Our preclinical studies suggest that we are making progress toward achieving our goal: PF-06463922 has potent ALK-inhibiting activity, it is capable of inhibiting all the crizotinib-resistant ALK mutants so far detected in patients, and it can efficiently access the brain. We are excited about these preclinical results and very hopeful that they will translate into meaningful responses in the clinic."

After carefully designing PF-06463922, Smeal and colleagues first showed in cell assays that it potently inhibited the activity of ALK and all eight of the mutant forms of ALK known to cause resistance to crizotinib
'/>"/>

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Targeted therapeutics for colon cancer to be presented at AACR meeting
2. First targeted nanomedicine to enter human clinical studies
3. Highly targeted irradiation as good as whole breast radiotherapy in early stage cancer
4. Dana-Farber: Study reports first success of targeted therapy in type of non-small cell lung cancer
5. Inflammatory pathway spurs cancer stem cells to resist HER2-targeted breast cancer treatment
6. Killer infections targeted by hospital study
7. Lower risk of serious side-effects in trials of new targeted drugs
8. Treating drug resistant cancer through targeted inhibition of sphingosine kinase
9. Pitt: Targeted oxidation-blocker prevents secondary damage after traumatic brain injury
10. Deadly witch hunts targeted by grassroots womens groups
11. Large lung cancer study shows potential for more targeted therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 ADOAMNI, Inc. ... campaign through GoFundMe. The campaign, which surpassed its goal ... portion of the funds necessary to convert a diesel ... Stockton Unified School District (SUSD). The campaign rallied citizens ... portion of the funds necessary for the conversion of ...
(Date:9/30/2014)... 2014 The American Parkinson ... funding supporting seven Research grants to junior investigators ... to support post-doctoral scientists whose research training holds ... etiology and treatment of Parkinson’s disease, and eight ... and medical centers across the country intended to ...
(Date:9/30/2014)... With accolades like the Most Inspirational Lash Artist ... Brand of My Brand Lashes is a leader of lash ... the ability to teach. She leads with a passion for ... reputation. , With a background in Cosmetology that spans 11 ... and as an Instructor. She has operated two of her ...
(Date:9/30/2014)... Got grapes? UCLA researchers have demonstrated how resveratrol, an ... to inhibit growth of the bacteria that causes acne. ... a common acne medication, benzoyl peroxide, may enhance the ... into new treatments. , Published in the current online ... the early lab findings demonstrated that resveratrol and benzoyl ...
(Date:9/30/2014)... -- MIT engineers have devised a way to rapidly ... making it easier to discover promising new ways to ... antibodies, peptides, RNA, and DNA, to human patients. , ... Biology , the researchers used this technology to identify ... also to rodents. This type of high-speed screen could ...
Breaking Medicine News(10 mins):Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 2Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 3Health News:The American Parkinson Disease Association Awards $1.1 million in Research Grants and Continues to Lead the Way to Ease the Burden – Find the Cure for Parkinson’s Disease 4Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 2Health News:My Brand Lashes and Lash Affair By J. Paris Merge to Offer Premium Lash and Brow Products and Certifications 3Health News:Antioxidant found in grapes uncorks new targets for acne treatment 2Health News:Antioxidant found in grapes uncorks new targets for acne treatment 3Health News:High-speed drug screen 2Health News:High-speed drug screen 3
... (NP) is pleased to share today the release of Mr. Umar ... the Mindanao region of the Philippines who was kidnapped from the ... 13. Jaleel is alive and is currently en route to ... the vicinity of Tipo Tipo on Basilan. Jaleel was released ...
... , ... final program for Biopolymers Symposium 2009 taking place September 28 - 30th in Chicago, ... ... -- IntertechPira is pleased to announce the Biopolymers Symposium 2009 conference and exhibit, taking ...
... A. Magana awarded $25,000 each for leadership in increasing diversity ... 3 Guillermo J. Camacho, a dentist in West Covina, ... at California State Polytechnic University, Pomona, that encourages students of ... founded and directs a program at Cabrillo College ...
... if you,re a woman trying to figure out how to please her ... the gift you really want for yourself. , , (Photo: ... that probably rules out the ,65 Mustang and the even-bigger screen TV. ... for millions of women - one that would actually be a true ...
... for early confirmation of bile duct, pancreatic cancers, , WEDNESDAY, ... have developed new tests that make it easier to diagnose ... study, the new tests more than doubled the detection rate ... are not discovered until their later stages. , "The earlier ...
... , Health insurer chooses Cincom Eloquence to streamline policy ... software provider Cincom Systems announces that Medica ( ... to more than 1.5 million members, has chosen Cincom ... document automation processes. , , Key considerations for ...
Cached Medicine News:Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 2Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 3Health News:Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 3Health News:Perfect Father's Day Gift: The Sound of Silence 2Health News:Perfect Father's Day Gift: The Sound of Silence 3Health News:New Tests Spot Tough-to-Detect Cancers Sooner 2Health News:Medica Selects Cincom's Document Automation Software 2Health News:Medica Selects Cincom's Document Automation Software 3
(Date:9/30/2014)... 2014   Acutus Medical, Inc. (ACM), ... 3D Cardiac Chamber Imaging and Dipole Density Mapping system ... sustain complex cardiac arrhythmias, including atrial fibrillation, announced it ... its imaging/mapping system as well as bring to market ... Medical to complete work on the AcQMap TM ...
(Date:9/30/2014)... , Sept. 30, 2014 One week after ... major milestone: Alzheimer,s Team reaches over 200,000 ... and caregivers, was developed to draw attention to clinical ... disease. It also provides inspirational support and fosters online ... as the leading healthcare concern for people over the ...
(Date:9/30/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology, announced today that ... a finalist in the Diagnostics & Research Tools ... Awards, sponsored by CONNECT. CONNECT, a regional program that ... sciences products in San Diego County ...
Breaking Medicine Technology:Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 2MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 3MediciGlobal's Alzheimer's Community Reaches 200,000 likes and more than half a million weekly visitors 4Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3
... SPRING, Md., June 24, 2011 Breast cancer patients and ... 7:00 am outside of the Federal Drug Administration (FDA).  At ... anti-cancer drug Avastin from the approved medication list for treatment ... in 2008 for use to treat breast cancer. ...
...   - Dossier Re-Examination ... a leader in,the field of human gene therapy, ... its Marketing Authorisation Application,(MAA) for Glybera® (alipogene tiparvovec) ... Following a recent,meeting with the European Medicines Agency,s ...
Cached Medicine Technology:Breast Cancer Patients and Families Stand Up To FDA 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 2Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 3Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application 4
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
Medicine Products: